KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Change in Inventory: 2021-2024

Historic Change in Inventory for Novavax (NVAX) over the last 4 years, with Dec 2024 value amounting to -$12.9 million.

  • Novavax's Change in Inventory rose 249.77% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year increase of 126.32%. This contributed to the annual value of -$12.9 million for FY2024, which is 117.34% down from last year.
  • According to the latest figures from FY2024, Novavax's Change in Inventory is -$12.9 million, which was down 117.34% from $74.5 million recorded in FY2023.
  • In the past 5 years, Novavax's Change in Inventory registered a high of $477.8 million during FY2022, and its lowest value of -$12.9 million during FY2024.
  • In the last 3 years, Novavax's Change in Inventory had a median value of $74.5 million in 2023 and averaged $179.8 million.
  • Its Change in Inventory has fluctuated over the past 5 years, first soared by 5,285.49% in 2022, then tumbled by 117.34% in 2024.
  • Novavax's Change in Inventory (Yearly) stood at $8.9 million in 2021, then spiked by 5,285.49% to $477.8 million in 2022, then slumped by 84.42% to $74.5 million in 2023, then tumbled by 117.34% to -$12.9 million in 2024.